Kodiak Sciences Inc (KOD)

Kodiak Sciences (KOD) Stock Price & Analysis


KOD Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$4.90 - $12.80
Previous Close$5.12
Average Volume (3M)261.13K
Market Cap
Enterprise Value-$181.74M
Total Cash (Recent Filing)$537.39M
Total Debt (Recent Filing)$87.83M
Price to Earnings (P/E)-0.7
May 16, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.83
Shares Outstanding52,309,154
10 Day Avg. Volume190,404
30 Day Avg. Volume261,126
Standard Deviation0.31
Financial Highlights & Ratios
Price to Book (P/B)0.81
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-2.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.52
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Kodiak Sciences Inc’s price range in the past 12 months?
Kodiak Sciences Inc lowest stock price was $4.90 and its highest was $12.80 in the past 12 months.
    What is Kodiak Sciences Inc’s market cap?
    Currently, no data Available
    When is Kodiak Sciences Inc’s upcoming earnings report date?
    Kodiak Sciences Inc’s upcoming earnings report date is May 16, 2023 which is in 56 days.
      How were Kodiak Sciences Inc’s earnings last quarter?
      Currently, no data Available
      Is Kodiak Sciences Inc overvalued?
      According to Wall Street analysts Kodiak Sciences Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Kodiak Sciences Inc pay dividends?
        Kodiak Sciences Inc does not currently pay dividends.
        What is Kodiak Sciences Inc’s EPS estimate?
        Kodiak Sciences Inc’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Kodiak Sciences Inc have?
        Kodiak Sciences Inc has 52,309,155 shares outstanding.
          What happened to Kodiak Sciences Inc’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Kodiak Sciences Inc?
          Among the largest hedge funds holding Kodiak Sciences Inc’s share is Baker Bros Advisors LP. It holds Kodiak Sciences Inc’s shares valued at 124M.


            Kodiak Sciences Stock Smart Score

            The Kodiak Sciences stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
            Learn more about TipRanks Smart Score

            Company Description

            Kodiak Sciences Inc

            Kodiak Sciences, Inc. is a a clinical-stage biopharmaceutical company, which engages in the development of novel therapies for the treatment of retinal diseases. Its product pipeline include KSI-301 for wet AMD; KSI-301 for diabetic eye disease; KSI-501 for DME and uveitis; KSI-201 for resistant wet AMD; and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.


            Forecast EPS vs Actual EPS

            Currently, no data available
            Please return soon. This page is being updated.

            Similar Stocks
            Price & Change
            Scholar Rock Holding
            C4 Therapeutics
            Lexicon Pharmaceuticals
            Poseida Therapeutics
            Arbutus Biopharma

            Popular Stocks

            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis